Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Yoel Cruz, ARNP
Nurse Practitioner · ONEIDA, NY · NPI 1427492073
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Eliquis | Apixaban | 317 | 81 |
| Atorvastatin Calcium | Atorvastatin Calcium | 302 | 144 |
| Amlodipine Besylate | Amlodipine Besylate | 244 | 96 |
| Gabapentin | Gabapentin | 218 | 103 |
| Metoprolol Succinate | Metoprolol Succinate | 208 | 88 |
| Furosemide | Furosemide | 198 | 91 |
| Tramadol Hcl | Tramadol Hcl | 169 | 68 |
| Levothyroxine Sodium | Levothyroxine Sodium | 166 | 86 |
| Sertraline Hcl | Sertraline Hcl | 150 | 56 |
| Lisinopril | Lisinopril | 134 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 130 | 87 |
| Metoprolol Tartrate | Metoprolol Tartrate | 116 | 60 |
| Oxycodone Hcl | Oxycodone Hcl | 108 | 57 |
| Buspirone Hcl | Buspirone Hcl | 105 | 49 |
| Potassium Chloride | Potassium Chloride | 100 | 60 |
| Morphine Sulfate | Morphine Sulfate | 98 | 59 |
| Tamsulosin Hcl | Tamsulosin Hcl | 96 | 53 |
| Xarelto | Rivaroxaban | 96 | 34 |
| Mirtazapine | Mirtazapine | 94 | 41 |
| Duloxetine Hcl | Duloxetine Hcl | 89 | 31 |
| Losartan Potassium | Losartan Potassium | 84 | 44 |
| Levetiracetam | Levetiracetam | 82 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 80 | 46 |
| Lorazepam | Lorazepam | 79 | 56 |
| Metformin Hcl | Metformin Hcl | 67 | 38 |
| Carvedilol | Carvedilol | 65 | 26 |
| Torsemide | Torsemide | 64 | 35 |
| Spironolactone | Spironolactone | 62 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 59 | 35 |
| Escitalopram Oxalate | Escitalopram Oxalate | 58 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 58 | 17 |
| Risperidone | Risperidone | 57 | 13 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 56 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 56 | 34 |
| Ondansetron Hcl | Ondansetron Hcl | 55 | 45 |
| Prednisone | Prednisone | 55 | 24 |
| Omeprazole | Omeprazole | 53 | 39 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | 18 |
| Divalproex Sodium | Divalproex Sodium | 52 | 24 |
| Warfarin Sodium | Warfarin Sodium | 47 | suppressed |
| Jardiance | Empagliflozin | 46 | 21 |
| Clozapine | Clozapine | 45 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 44 | 24 |
| Trazodone Hcl | Trazodone Hcl | 42 | 27 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 42 | 16 |
| Midodrine Hcl | Midodrine Hcl | 41 | 19 |
| Myrbetriq | Mirabegron | 41 | 12 |
| Trulicity | Dulaglutide | 41 | 16 |
| Latanoprost | Latanoprost | 40 | 21 |
| Amiodarone Hcl | Amiodarone Hcl | 39 | 15 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 38 | 36 |
| Baclofen | Baclofen | 38 | 14 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 37 | 14 |
| Allopurinol | Allopurinol | 36 | 24 |
| Alprazolam | Alprazolam | 35 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 32 | 11 |
| Simvastatin | Simvastatin | 32 | 17 |
| Farxiga | Dapagliflozin Propanediol | 30 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 30 | 20 |
| Levofloxacin | Levofloxacin | 29 | 23 |
| Donepezil Hcl | Donepezil Hcl | 28 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 28 | 11 |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 28 | 13 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 28 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Atenolol | Atenolol | 27 | 12 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 27 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 27 | 12 |
| Pregabalin | Pregabalin | 27 | 12 |
| Azithromycin | Azithromycin | 26 | 23 |
| Finasteride | Finasteride | 26 | 17 |
| Lacosamide | Lacosamide | 26 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Trexall | Methotrexate Sodium | 25 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 24 | 13 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 23 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 23 | 21 |
| Albuterol Sulfate | Albuterol Sulfate | 22 | 18 |
| Famotidine | Famotidine | 22 | 20 |
| Humalog | Insulin Lispro | 22 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | 17 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 22 | 12 |
| Januvia | Sitagliptin Phosphate | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | 11 |
| Clonidine Hcl | Clonidine Hcl | 19 | 15 |
| Ibuprofen | Ibuprofen | 19 | 18 |
| Letrozole | Letrozole | 19 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 18 | 11 |
| Enoxaparin Sodium | Enoxaparin Sodium | 18 | suppressed |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Invokana | Canagliflozin | 18 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | 11 |
| Vraylar | Cariprazine Hcl | 18 | suppressed |
| Clonazepam | Clonazepam | 17 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 17 | 14 |
| Digoxin | Digoxin | 17 | 15 |
| Fluconazole | Fluconazole | 17 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Sucralfate | Sucralfate | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | 12 |
| Ceftriaxone | Ceftriaxone Sodium | 16 | 13 |
| Celecoxib | Celecoxib | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Haloperidol | Haloperidol | 16 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 16 | 12 |
| Lidocaine Hcl | Lidocaine Hcl | 16 | 15 |
| Memantine Hcl | Memantine Hcl | 16 | 13 |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Bupropion Xl | Bupropion Hcl | 15 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 15 | suppressed |
| Clindamycin Phosphate | Clindamycin Phosphate | 14 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 14 | suppressed |
| Dexamethasone | Dexamethasone | 14 | suppressed |
| Folic Acid | Folic Acid | 14 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 14 | suppressed |
| Lactulose | Lactulose | 14 | 11 |
| Montelukast Sodium | Montelukast Sodium | 14 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Topiramate | Topiramate | 14 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Admelog Solostar | Insulin Lispro | 12 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 12 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 12 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 12 | suppressed |
| Estradiol | Estradiol | 12 | suppressed |
| Ezetimibe | Ezetimibe | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Linezolid | Linezolid | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | 11 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 11 | suppressed |
| Glimepiride | Glimepiride | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Loperamide | Loperamide Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error